Skip to main content

Table 1 Patient and tumor demographics

From: Concurrent renal cell carcinoma and urothelial carcinoma: long-term follow-up study of 27 cases

 

n = 27

Age (years), median (range)

69 (37–79)

Sex, n (%)

 Male

22 (81.5%)

 Female

5 (18.5%)

Smoke

 Yes

13 (48.1%)

 No

14 (51.9%)

Symptom

 Hematuria

17 (63.0%)

 No

10 (37.0%)

UC location

 UTUC

9 (33.3%)

 BT

16 (59.3%)

 UTUC + BT

2 (7.4%)

RCC size (cm), median (range)

3.5 (0.6–14.5)

RCC stage

 T1

21 (77.8%)

 T2

4 (14.8%)

 T3

2 (7.4%)

RCC grade

 G1

8 (29.6%)

 G2

16 (59.3%)

 G3

3 (11.1%)

UC stage

 Ta/T1

18 (66.7%)

 T2

4 (14.8%)

 T3

3 (11.1%)

 T2(UTUC) + T1(BT)

1 (3.7%)

 T1(UTUC) + T1(BT)

1 (3.7%)

Number of tumor

 2

21 (77.8%)

 3

4 (14.8%)

 4

2 (7.4%)

Hydronephrosis

 Yes

7 (25.9%)

 No

20 (74.1%)

Distant metastases, n (%)

2 (7.4%)

  1. UC urothelial carcinoma, RCC renal cell carcinoma, UTUC upper tract urothelial carcinoma, BT bladder tumor